Work

Supplementary Figure S12 from Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids

Year: 2024

Type: supplementary-materials

Abstract: Supplementary Figure S12. Validation of AKR1B10 expression in an internal cohort of sensitive (n = 7) and resistance (n = 7) patient tumors to platinum-based doublet therapy.

DOI: 10.1158/1078-0432.26926681.v1

Authors: Kanve N. Suvilesh, Yariswamy Manjunath, Yulia I. Nussbaum, Mohamed Gadelkarim, Murugesan Raju, Akhil Srivastava, Guangfu Li, Wesley C. Warren, Chi-Ren Shyu, Feng Gao, Matthew A. Ciorba, Jonathan B. Mitchem, Satyanarayana Rachagani, Jussuf T. Kaifi

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4402173663

Cites:

Cited by:

Related to: 10